← Leaderboards
Randy Schrecengost
Thomas Jefferson University
$644,861
Attributed
$644,861
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $275K · FY2011–23$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$644,861 · 3
By mechanism
R43$555,000 · 2
F32$89,861 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Ya Wang$3,768,156
- John Eisenbrey$7,634,263
- Edouard John Trabulsi$2,221,350
- William R Davidson$147,891
- Adam Paul Dicker$1,271,915
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsIn VivoPathway InteractionsDiagnosisMediatingTumorEffective TherapyPlayRadiation TherapyIn VitroTumor ProgressionGenetic TranscriptionCessation Of LifeReceptorResistanceProtein ExpressionClinically RelevantBaseProteinsSignal TransductionAutomobile DrivingAndrogen ReceptorMalignant Neoplasm Of ProstateModification
Grant awards (5)
Development of GB13 for the Treatment of Pediatric Diffuse Intrinsic Pontine Glioma$55,000
R43 · FY2023 · CA · contact PI
Development of GB13 for the Treatment of Pediatric Diffuse Intrinsic Pontine Glioma$275,000
R43 · FY2022 · CA · contact PI
Radiosensitizing Prostate Cancer by Downregulation of Androgen Receptors and c-Myc$225,000
R43 · FY2015 · CA · contact PI
USP22 is a Novel Target for Prostate Cancer Therapy$41,463
F32 · FY2012 · CA · contact PI
USP22 is a Novel Target for Prostate Cancer Therapy$48,398
F32 · FY2011 · CA · contact PI